Try our Advanced Search for more refined results
Life Sciences - December, 2021
243 articles
- NY Jury Holds Teva Liable After Opioid Trial
- The Most-Read Legal Industry Guest Articles Of 2021
- Holmes Jury Asks To Rehear Ex-CEO's 2013 Investor Call
- Endo Gives Texas $63M In Latest Opioid Deal
- High Court To Review Federal Vaccine Mandates Next Month
- 5th Circ. Won't Revive Walmart's Opioid Suit Against Feds
- Opioid Judge's 'Many Errors' Ruined Trial, Pharmacies Charge
- Allergan Unit Says Linda Evangelista's $50M Suit Time-Barred
- Vaxart Can't Ditch Claims Co. Lied To Investors About Vaccine
- Judge Told CardioNet Owes $2.9M In Fees For 'Misconduct'
- Justices Told To Undo 'Impossible' Patent Enablement Rules
- CBD Co. Seeks Quick Win Over Ex-CEO In $5M Tax Bill Row
- Moderna Faces Complaint To SEC Over Vax Patent Row
- Pfizer Gets FDA Emergency Use Authorization For COVID Pills
- Judge Overrules 'State Secrets' Concerns In Valsartan MDL
- What DOJ's Cyberfraud Initiative Means For Health Cos.
- A Law Firm Leader's Guide To Seeking Effective Feedback
- Reed Smith-Advised Health Care SPAC Makes $75M Offering
- Top 5 Government Contracts Of 2021
- Novartis Inks Up To $1.5B Deal For Gyroscope Therapeutics
- UK Litigation Roundup: Here's What You Missed In London
- Janssen Denied Early Defeat Of HIV Medication FCA Suit
- DOJ Opioid Trial Team Tainted By Kirkland Ties, Ex-CEO Says
- Maine Asks 1st Circ. To Uphold Medical Pot Residency Rule
- 27 States, Groups Appeal Vax-Or-Test Rule To Justices
- Ill. Judge Refuses To Block Chicago, State Vax Mandates
- Holmes Judge Nixes Jury Request To Take Instructions Home
- Fla. Man Fights Pfizer's Escape Bid For Chantix Suit
- Purdue Asks To Keep Lawsuits Frozen Pending Ch. 11 Appeal
- Biden's Omicron Plan Details More At-Home Tests, Vax Sites
- Mylan Says Unharmed EpiPen Loyalists Undercut Class Cert.
- How Medical Device Cos. Can Limit Enforcement, Legal Risks
- Boston Scientific's Alice Challenge Flops In Del.
- Recalled P&G Deodorants Contained Carcinogens, Suit Claims
- Washington Nationals Tap Lorenger & Carnell For Vax Suit
- Weil, Fenwick Steer Sanofi's Up To $1.2B Deal For Amunix
- NJ Firm Wants To Toss Suit Over Benicar MDL Atty Fees
- Smith & Nephew Tries To Sink Pre-2009 Hip Implant Claims
- Major Merger Review Moments From 2021
- 11th Circ. Backs Hollister's $9M Win In Incontinence IP Row
- AbbVie Urges ITC To Block Humira Rival Over Trade Secrets
- Del. Judge Upholds Claims In Opioid Drug IP But Axes Others
- University Of Chicago Prof. Charged With Insider Trading
- Insurers Tell 11th Circ. To Nix Medical Co.'s Coverage Suit
- NJ Judge Won't Toss FCA Suit Over J&J Unit's Cancer Drug
- Embracing ESG: Whirlpool CLO Talks Structural Improvement
- 4 Big Issues That Shaped The PTAB In 2021
- Fed. Circ. Written Description Scrutiny Has Lessons For Attys
- Moderna Backs Off COVID Vaccine Patent In Dispute With NIH
- Holmes' Fate In Jury's Hands As Criminal Fraud Trial Wraps
- ITC Bans Chinese Massage Gun Imports Over Infringement
- Mallinckrodt Balks At Bid To Withdraw Acthar Antitrust Claims
- Apotex Asks Justices To Make Fed. Circ. Use Less 'Rigid' Test
- Seismic Purdue Ruling May Finally Get High Court's Attention
- LA Fitness Blames Virus For Closures In Revised Suit
- Cannabis Bill Roundup: GOP Reps. Chide Biden's Pot Inaction
- CBD Store Franchisee Launches New Suit Against Company
- Amtrak Vaccine Mandate Suit's Fate Uncertain After Ga. Ruling
- Fla. High Court Is Wrong To Ban CLE Diversity Requirements
- The 6 Most Important Bid Protest Decisions Of 2021
- Health Hires: Balt, McDermott Will & Emery
- Elite Horse Trainer Navarro Gets 5 Years In Doping Scandal
- Worker Can't Be Fired For Rebutting Review, Mass. Court Says
- Taxation With Representation: Skadden, Wachtell, Simpson
- 7th Circ. Revives 2 Cook Medical Vein Filter Suits
- IPO Stampede Powered Record Capital Markets Activity In '21
- BGI Units Lose Appeal Over Illumina DNA Sequencing IP
- UK Litigation Roundup: Here's What You Missed In London
- Biden Asks Supreme Court To Revive Health Worker Vax Rule
- Feds Portray Holmes As Mature Liar As Fraud Trial Nears End
- FDA To Allow Abortion Pills By Mail, Amid High Court Clash
- FDA Tosses Par Pharma's Anti-Generic Bid, Vows FTC Referral
- IP Forecast: Feds To Spar With Gilead Over CEO's Testimony
- Purdue Pharma's Ch. 11 Plan Is Unraveled On Appeal
- CDC Panel Recommends Pfizer, Moderna Over J&J Vax
- Texas Court Temporarily Stops Health Care Vaccine Mandate
- Lawyers Must Prepare For Contract Tech Co. Consolidation
- Bimbo Bakeries Sued In Wash. Over Toxic Metal Discharge
- Cravath Hires Assistant Director From FTC Merger Division
- Coppertone Buyers Get Final OK For $2.25M False Ad Deal
- High Court Speeds Up Texas Abortion Fight In 5th Circ.
- US Trustee Seeks Ch. 11 Examiner For J&J Talc Liability Unit
- Chancery Denies Alexion's Call To Revisit Fee Shift Ruling
- Disputing Plaintiff Expert Testimony In Product Liability Cases
- Defunct Opioid Distributor's Compliance Manager Takes Plea
- Holmes' 'Risky' Decision To Testify Could Save Her, Attys Say
- Mylan Can't Decertify EpiPen Antitrust Action Ahead Of Trial
- US Hemp Roundtable Pushes Back Against Ore. CBD Rules
- Cannabis Advocacy Org Urges Fed Action On CBD Regulation
- 5th Circ. Dials Back Block Of Health Care Vaccine Mandate
- Centene Hits Gilead With HIV Generic Antitrust Suit
- The Biggest Trademark Rulings Of 2021
- FDA Sends Medtronic Warning Over Diabetes Facility Issues
- Patent Groups Spar With Big Tech Over $2.7B Cisco Loss
- Jones Day Can Rep J&J Talc Unit In Ch. 11 For Now
- AbbVie's $550M Medical Device Deal Moving Ahead
- BigLaw's Big Guns Of Revenue Keep Growing
- Skadden, Wachtell Lead $6.5B Chipmaking Materials Co. Deal
- Opioid Makers Cement Calif. Win As Judge Spurns Objections
- Fed. Circ. Backs Ax Of Sunbio's Supplement TM
- Puma Biotech Investors Ink $54M Deal Over Drug Statements
- 4 Highlights From FDA Nominee Hearing
- Fla. Judge Trims Woman's Claims In Belviq Cancer Lawsuit
- CBD Co. Sued By Ex-CEO Over Surprise $5M Tax Bill
- Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial
- What New FDA Policy Means For COVID Tests And Beyond
- Product Liability Risks Cannabis Companies Must Consider
- The Pandemic Patent Lawsuit Boom Continues
- How Firms Can Adapt Amid COVID's Shifting Legal Needs
- Ex-Pharma Worker's 'Dark Web' Suit Can Stand, 3rd Circ. Told
- Pharma Co. Seeks To Deny Novartis' 'Speculative' DQ Bid
- 3-Part Ch. 11 Stalking Horse Sale OK'd For Teligent
- Monsanto Successors Agree To $17.9M Superfund Cleanup
- Prestige Draws Young Attys, But Keeping Them Takes Work
- 4 Firms Assemble $11.6B Deal For Swiss Pharma Co.
- Split 5th Circ. Won't Block United Vax Mandate Amid Appeal
- NY Opioid Deliberations Delayed After Rancorous Closing Day
- Vanessa Hudgens Says Beauty Brand Faked Her Endorsement
- Mallinckrodt Says $1.75B Ch. 11 Opioid Deal Is Reasonable
- The Biggest Patent Rulings Of 2021
- Justices Won't Review FTC's Impax Ruling
- Contractor Says Resold Workout Machines Are Fed's Problem
- Embracing ESG: Synchrony Counsel Talk Role Of Legal Teams
- High Court Won't Block NY Health Care Worker Vax Mandate
- PTAB Discretionary Denials Are Unpredictable And Illegal
- Pa. DAs Say AG's $26B Opioid Deal Steps On Their Suits
- High Court Wants Feds' Input On $25M Roundup Verdict
- Justices Won't Hear J&J Challenge To Miss. AG's Talc Trial
- Prestige Leaders: A Look At Our New Law Firm Ranking
- The 2021 Law360 Pulse Prestige Leaders
- Prestige Leaders: Sizing Up Firms By Revenue
- 3 Firms Draw Up Pfizer's $6.7B Arena Pharmaceuticals Buy
- Holmes Jury Instructions Fight Touches On Celebrity, Balwani
- Court Asked To Create Fund In Atrium Defective Mesh MDL
- One Of 3M's N95 TM Suits Just Got More Complicated
- Cannabis Bill Roundup: The Prefiling Season Kicks Off
- The Top Product Liability Cases Of 2021
- Shkreli, Vyera To Settle Out Of BCBS Antitrust Class Action
- Mallinckrodt Calls Opioid, Acthar Deals Vital To Ch. 11 Plan
- House Report Finds 'Unfair' Drug Pricing Practices
- USPTO May Ditch Paper Patents, Trademark Certificates
- Rite Aid Broke Law By Changing Benefits, NLRB Judge Finds
- J&J Talc Spinoff's Ch. 11 Masquerading As Legit, Court Told
- Taxation With Representation: Ashurst, Freshfields, Gibson
- Short Sale Verdict Shows Need For Better Portfolio Disclosure
- Justices Let Texas Keep Its Abortion Law, But Clinics Can Sue
- Monsanto Snags Another Jury Victory In Calif. Roundup Trial
- US Trustee Wants Jones Day Booted From J&J Talc Ch. 11
- IP Forecast: Amazon To Fight Damages Theory In Patent Row
- No Teva Execs Testified In NY Opioid Trial, Jury Told
- Federal Judge Puts Calif. Pay-For-Delay Ban On Hold
- No Reconsideration Of Dismissal In DePuy Hip Implant Suit
- Deals Rumor Mill: Porsche, DuPont, Uber
- Hatch-Waxman Act Suits Set For 9-Year Low In 2021
- WilmerHale Steers Jeb Bush-Led SPAC's $200M IPO
- Bradley Arant Adds Ex-Gibson Dunn Atty To Litigation Team
- 3rd Fla. Federal Judge Recuses Himself In Battle Over Fees
- IPR's Effect On District Court Cases: Overlooked Concerns
- For Junior Lawyers, Authenticity And A Solid Pitch Are Key
- J&J Hip Implant FCA Case Tossed Over Secret Info Use
- Feds Say Chicago Doc Used Veterinary Catheters On Humans
- Hemp Equipment Seller Should Face RICO Claim, Court Told
- Fed. Circ. Gives Mylan 2nd Chance To Ax AstraZeneca IP
- Theranos Closings Near As Elizabeth Holmes Rests Defense
- Talc Claimants Say J&J Abusing Ch. 11 With Trust Motion
- Chinese Lung Cancer Biotech Lands $200M In Funding
- Opioid Sales Parody Videos Didn't Sway Docs, Jury Told
- US Shouldn't Abandon Phase 1 Agreement With China
- Ex-Insys Staffer Skirts Prison For Fentanyl Bribe Scheme
- Jones Day Hires Mass Tort Partner In Ohio
- A Compliance Primer For Attorneys Outsourcing Legal Work
- BGI Units Appeal DNA Sequencing Infringement Ruling
- Allergan Strikes $200M Deal To Exit NY Opioid Trial
- Brown Rudnick Adds FDA Expert To Life Sciences Group
- 3 Firms Lead £1.2B PE Buyout Of British Pharma Co. Clinigen
- Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
- Former Shkreli Co. Inks Deal Worth Up To $40M With FTC, AGs
- Mallinckrodt Exec Says Ch. 11 Plan A Fair Deal For Creditors
- Opioid Jury Finally Sees Teva's Movie-Parody Sales Videos
- Fed. Circ. Won't Revive Teva Challenge To Drug Patent
- Full Fed. Circ. Told Teva Overreacting In Skinny Label IP Case
- What Vaccine Mandate Injunctions Mean For Health Employers
- Ex-Clinic Director Seeks Early Win In FCA Kickbacks Suit
- J&J Talc Sub Names Pick For Ch. 11 Future Claims Rep
- Why Boards Shouldn't Reject Investors' Misconduct Claims
- Supply Chain Indemnification Tips For Medical Device Cos.
- Robbins Geller, Friedlander & Gorris To Lead Biotech Sale Suit
- Solution To Patent Eligibility Quagmire Lies In Constitution
- 4 Firms Shape Biosimilar Biz Alvotech's $2.3B SPAC Deal
- When And How To Depose Fact Witnesses Remotely In 2022
- Fla. Pharmacy Owner Convicted Of Mail Fraud
- Jury Gives Composite Resources Win In Tourniquet IP Row
- Warby Parker Wants 1-800 Contacts' 'Thin' Search Suit Nixed
- 11th Circ. Denies Fla. Bid To Halt Fed Health Workers Vax Rule
- SEC Hits Dialysis Co., Execs With Accounting Fraud Claim
- Judge Puts End To E-Cig Patent Suit Against Philip Morris
- Justices Told Fed. Circ. Wrongly Kills Patents PTAB Upholds
- Feds Say NJ Pharma CEO Pilfered Nearly $4M From His Co.
- Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma
- Elite Horse Trainer Navarro Asks For Leniency In Doping Case
- Blood Clot Device Maker Must Face Suit In Ill., Court Rules
- JP Morgan Ruling May Have Broad Insurance Implications
- Embracing ESG: PayPal CLO Talks Gauging Impact And Intent
- Freshfields, Latham Lead Saint-Gobain's $2.3B Deal For GCP
- Mallinckrodt Escapes $320M Acthar Antitrust Claim In Ch. 11
- Hedge Fund Priest Seeks Total Victory Over SEC Stock Suit
- Feds Seek To Stay Order Blocking Contractor Vax Mandate
- Walgreens Medicaid FCA Suit Tossed Over Federal Law Clash
- Cannabis Bill Roundup: House Members Pitch New CBD Bill
- Holmes Attys Rip 'Confusing' Jury Instructions On Fraud
- UK Watchdog Clears Thermo Fisher's $21B PPD Deal
- States Say AMG Case Can't Save Drugmakers In Price-Fix Suit
- Maryland Atty Charged With $8.5M Escrow Fraud In NY Court
- Zoll Medical Escapes Liability For Alleged Defibrillator Defect
- How Growing Cyber Scrutiny Affects Corporate Compliance
- Class Attys Get $540K In Dollar General False Ad Suit
- New Patent Ownership Bill Should Better Balance Rights
- Medicinal Standards Org Urges More Testing Of Delta-8 THC
- NY Court Revives Faulty Heart Valve Replacement Suit
- Med Device Maker Valued At $2.25B In Minority Investment
- Advent, GIC Drop $8B Bid For Swedish Drugmaker Sobi
- UK Litigation Roundup: Here's What You Missed In London
- IP Forecast: 9th Circ. To Eye Class Cert. In Rock Music Fight
- Rockefeller U. Wins CRISPR Interference Battle At PTAB
- Blackstone REIT Lands $690M In Financing From 2 Banks
- Attys Seek $113M In Fees From Glumetza Buyers' $454M Deal
- FTC Pushing Caris Life Sciences For Merger Challenge Docs
- Former Pharma CFO, Ex-Girlfriend Accused Of Insider Trading
- 6th Circ. Affirms No Intervention In Flint Water Deal
- Gov't Contracts Of The Month: Meds, Jets, Military Moves
- Military Members Can't Fight DOD Vax Mandate Anonymously
- WTO Chief Wants Deal On Vaccines, Fisheries Early Next Year
- Lawmakers Urge VA To Let Vets Access Medical Pot
- Deals Rumor Mill: Lundin Energy, Vifor Pharma, Lone Star
- Fed. Circ. Won't Let Moderna Undo Rulings Tied To COVID Vax
- Buchanan Ingersoll Objects To Fee Split In Discovery Dispute
- Talc Claimants Seek To Toss J&J Unit's 'Manufactured' Ch. 11
- Judge Unsure If He Can Rule On Future Mallinckrodt Deal
- Imerys, Cyprus Get Go-Ahead For Mediation In Ch. 11 Cases
- Ohio Opioid Verdict Brings Focus To Role Of Pharmacists
- Climate Change Lawsuits Are Not 'The New Tobacco'
- Chancery Tosses Most Counts Aimed At Vaccine Firm Insiders
- NorthShore Workers Denied Injunction In Vax Mandate Suit